Adimmune Corp (國光生技) on Thursday said it is developing a COVID-19 vaccine in cooperation with the National Health Research Institutes, and plans to run animal tests in the second quarter if its research proceeds smoothly.
The Taichung-based firm has been working to develop the vaccine utilizing its recombinant protein technology since acquiring a genetic sequence from the US Centers for Disease Control last month, Adimmune spokesman Pan Fei (潘飛) told the Taipei Times by telephone.
As the virus’ sequence reportedly evolves and appears different in separate regions, the company is attempting to determine whether the difference is considerable enough to affect the efficacy of a vaccine, Pan said.
“Though the novel coronavirus’ genetic sequence is 70 percent similar to that of the SARS virus, it is still not easy to make the vaccine,” he said.
Earlier this month National Taiwan University managed to isolate the virus strain of COVID-19, and Medigen Vaccine Biologics Corp (高端疫苗) on Monday said that it expects to conduct clinical tests for its vaccine in the second half of this year.
Adimmune would not use the isolated virus strain during its development to protect the safety of its research team, Pan said, adding that it is hard to forecast when it would enter the human trial stage
The Central Epidemic Command Center on Thursday said that an infected Taiwanese businessman returning from Zhejiang Province in China last month had antibodies against the virus in his blood.
However, Adimmune said that those antibodies would not help in the development of vaccines.
“Antibodies are created by patients’ immune systems. However, our goal is to produce an antigen against the virus, which is different,” Pan said.
PATENTS: MediaTek Inc said it would not comment on ongoing legal cases, but does not expect the legal action by Huawei to affect its business operations Smartphone integrated chips designer MediaTek Inc (聯發科) on Friday said that a lawsuit filed by Chinese smartphone brand Huawei Technologies Co (華為) over alleged patent infringements would have little impact on its operations. In an announcement posted on the Taiwan Stock Exchange, MediaTek said that it would not comment on an ongoing legal case. However, the company said that Huawei’s legal action would have little impact on its operations. MediaTek’s statement came after China-based PRIP Research said on Thursday that Huawei filed a lawsuit with a Chinese district court claiming that MediaTek infringed on its patents. The infringement mentioned in the lawsuit likely involved
Taipei is today suspending work, classes and its US$2.4 trillion stock market as Typhoon Gaemi approaches Taiwan with strong winds and heavy rain. The nation is not conducting securities, currency or fixed income trading, statements from its stock and currency exchanges said. Authorities had yesterday issued a warning that the storm could affect people on land and canceled some ship crossings and domestic flights. Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) expects its local chipmaking fabs to maintain normal production, the company said in an e-mailed statement. The main chipmaker for Apple Inc and Nvidia Corp said it has activated routine typhoon alert
GROWTH: TSMC increased its projected revenue growth for this year to more than 25 percent, citing stronger-than-expected demand for AI devices and smartphones The Taiwan Institute of Economic Research (TIER, 台灣經濟研究院) yesterday raised its forecast for Taiwan’s GDP growth this year from 3.29 percent to 3.85 percent, as exports and private investment recovered faster than it predicted three months ago. The Taipei-based think tank also expects that Taiwan would see a 8.19 percent increase in exports this year, better than the 7.55 percent it projected in April, as US technology giants spent more money on artificial intelligence (AI) infrastructure and development. “There will be more AI servers going forward, but it remains to be seen if the momentum would extend to personal computers, smartphones and
CHANGE OF FORTUNES: Concern over a pricey valuation and the risk of tighter US curbs on chip sales to China have poured cold water on TSMC’s bullish momentum Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) shares fell the most in three months yesterday upon trading resumption, joining a global technology rout as investors dramatically soured on the promises of artificial intelligence (AI). The shares declined 5.62 percent to close at NT$924 in Taipei, dragging down the benchmark TAIEX, which fell 3.29 percent to 22,119.21 points amid a technical correction, Taiwan Stock Exchange data showed. Other chip stocks also fell, with ASE Technology Holding Co (日月光投控) plunging 9.86 percent, MediaTek Inc (聯發科) dropping 2.35 percent, Realtek Semiconductor Corp (瑞昱) falling 1.33 percent and United Microelectronics Corp (聯電) retreating 1.17 percent, while Apple